Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are also getting diagnosed, and at younger ages. -
Nearly half of women over 40 have dense breasts, which raises their risk of breast cancer. Mammograms should now include an assessment of breast tissue density. -
E-cigarettes hit the market about 20 years ago, and became a hit among teenagers. A new survey, however, finds far fewer teens used e-cigarettes over the past year.
-
An additional six people have died as the toll from contamination at a single Boar's Head plant becomes the worst listeria outbreak since 2011. Listeria is a bacterial, food-borne illness.
-
President Biden traveled to New Orleans this week to announce a $150 million investment in technologies to improve cancer surgeries. We check in on the progress of Cancer Moonshot.
-
Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity. -
There are lots of reasons people have to stop taking the new weight loss drugs: cost, shortages, side effects and life events. And the weight usually comes back, doctors say. -
Are Americans too stressed to sleep? A recent Gallup poll shows just how sleep-deprived we are.
-
Scientific advances in immunotherapy and new targeted therapies have increased survival rates. But screening among former and current smokers still needs to improve to save more lives. -
CDC research finds that in addition to cost and access, other factors of daily life keep many women from getting screened for breast cancer. (Story aired on All Things Considered on 4/9/24.)
